Chibnik LB - Search Results

1

Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance.

Costenbader KH, Chibnik LB, Schur PH. Costenbader KH, et al. Among authors: chibnik lb. Clin Exp Rheumatol. 2007 Sep-Oct;25(5):746-9. Clin Exp Rheumatol. 2007. PMID: 18078625

2

Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature.

Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A. Waziry R, et al. Among authors: chibnik lb. Neurology. 2020 Feb 11;94(6):265-272. doi: 10.1212/WNL.0000000000008924. Epub 2020 Jan 16. Neurology. 2020. PMID: 31949087 Free PMC article. Review.

3

Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center.

Agarwal SK, Maier AL, Chibnik LB, Coblyn JS, Fossel A, Lee R, Fanikos J, Fiumara K, Lowry C, Weinblatt ME. Agarwal SK, et al. Among authors: chibnik lb. Arthritis Rheum. 2005 Dec 15;53(6):872-8. doi: 10.1002/art.21582. Arthritis Rheum. 2005. PMID: 16342095

4

Development of a preliminary index that predicts adverse events after total knee replacement.

Solomon DH, Chibnik LB, Losina E, Huang J, Fossel AH, Husni E, Katz JN. Solomon DH, et al. Among authors: chibnik lb. Arthritis Rheum. 2006 May;54(5):1536-42. doi: 10.1002/art.21772. Arthritis Rheum. 2006. PMID: 16645987

5

Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.

Benito-Garcia E, Heller JE, Chibnik LB, Maher NE, Matthews HM, Bilics JA, Weinblatt ME, Shadick NA. Benito-Garcia E, et al. Among authors: chibnik lb. J Rheumatol. 2006 Jul;33(7):1275-81. J Rheumatol. 2006. PMID: 16821266 Clinical Trial.

6

Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women.

Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H, Fraser PA, Karlson EW. Finckh A, et al. Among authors: chibnik lb. Arthritis Rheum. 2006 Nov;54(11):3648-54. doi: 10.1002/art.22210. Arthritis Rheum. 2006. PMID: 17075811

7

A pravastatin dose-escalation study in systemic lupus erythematosus.

Costenbader KH, Liang MH, Chibnik LB, Aizer J, Kwon H, Gall V, Karlson EW. Costenbader KH, et al. Among authors: chibnik lb. Rheumatol Int. 2007 Sep;27(11):1071-7. doi: 10.1007/s00296-007-0341-6. Epub 2007 Apr 3. Rheumatol Int. 2007. PMID: 17404733 Clinical Trial.

8

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.

Todd DJ, Kagan A, Chibnik LB, Kay J. Todd DJ, et al. Among authors: chibnik lb. Arthritis Rheum. 2007 Oct;56(10):3433-41. doi: 10.1002/art.22925. Arthritis Rheum. 2007. PMID: 17907148

9

Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis.

Liao KP, Batra KL, Chibnik L, Schur PH, Costenbader KH. Liao KP, et al. Ann Rheum Dis. 2008 Nov;67(11):1557-61. doi: 10.1136/ard.2007.082339. Epub 2008 Jan 30. Ann Rheum Dis. 2008. PMID: 18234714 Free PMC article.

10

Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.

Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH. Lee DM, et al. Among authors: chibnik lb. Ann Rheum Dis. 2009 Feb;68(2):201-8. doi: 10.1136/ard.2007.084509. Epub 2008 Apr 7. Ann Rheum Dis. 2009. PMID: 18390910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results